Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort
Ragnhild Hellesnes, Tor Åge Myklebust, Sophie D. Fosså, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 32, pp. 3561-3573
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Cisplatin for cancer therapy and overcoming chemoresistance
Ranmali Ranasinghe, Michael L. Mathai, Anthony Zulli
Heliyon (2022) Vol. 8, Iss. 9, pp. e10608-e10608
Open Access | Times Cited: 75
Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life
Sjoukje Lubberts, Harmke J. Groot, Ronald de Wit, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 19, pp. 3512-3522
Open Access | Times Cited: 17
Zeolitic Imidazole Framework/Silica Nanocomposite for Targeted Cancer Therapeutics: Comparative Study of Chemo-Drug Cisplatin (CPt) and Green Platinum (GPt) Efficacy
Hend Ghnaim Alotaibi, Eman A. Alabbad, Dana Almohazey, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3157-3157
Open Access | Times Cited: 6
Testicular Cancer: Biology to Bedside
Jennifer King, Nabil Adra, Lawrence H. Einhorn
Cancer Research (2021) Vol. 81, Iss. 21, pp. 5369-5376
Open Access | Times Cited: 33
Epigenetics and Testicular Cancer: Bridging the Gap Between Fundamental Biology and Patient Care
Alina-Teodora Nicu, Cosmin Medar, Mariana Carmen Chifiriuc, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 27
Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience
Anna Thor, Helene F. S. Negaard, Anna Grenabo Bergdahl, et al.
European Urology Open Science (2024) Vol. 65, pp. 13-19
Open Access | Times Cited: 5
Systemic Immune-Inflammation Index and Mortality in Testicular Cancer: A Systematic Review and Meta-Analysis
Farley E. Salazar-Valdivia, Valeria A. Valdez-Cornejo, Juan R. Ulloque‐Badaracco, et al.
Diagnostics (2023) Vol. 13, Iss. 5, pp. 843-843
Open Access | Times Cited: 11
Alkylating agents‐induced gonadotoxicity in prepubertal males: Insights on the clinical and preclinical front
Sruthi Sriram, T. Macedo, Annelies M. C. Mavinkurve‐Groothuis, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 3
Primary Mediastinal Germ Cell Tumors: A Thorough Literature Review
Güliz Özgün, Lucia Nappi
Biomedicines (2023) Vol. 11, Iss. 2, pp. 487-487
Open Access | Times Cited: 8
Long-term cardiotoxicity in germ cell cancer survivors after platinum-based chemotherapy: cardiac MR shows impaired systolic function and tissue alterations
Antonia Beitzen‐Heineke, Christina C. Rolling, Christoph Seidel, et al.
European Radiology (2023) Vol. 34, Iss. 6, pp. 4102-4112
Open Access | Times Cited: 8
The increasing burden of testicular seminomas and non-seminomas in adolescents and young adults (AYAs): incidence, treatment, disease-specific survival and mortality trends in the Netherlands between 1989 and 2019
Daniël J. van der Meer, Henrike E. Karim‐Kos, Henk W. Elzevier, et al.
ESMO Open (2024) Vol. 9, Iss. 2, pp. 102231-102231
Open Access | Times Cited: 2
Long-term quality of life of testicular cancer survivors differs according to applied adjuvant treatment and tumour type
Julia Heinzelbecker, Karla Kaßmann, Simone Ernst, et al.
Journal of Cancer Survivorship (2024)
Open Access | Times Cited: 2
Recent Advancements in Research on DNA Methylation and Testicular Germ Cell Tumors: Unveiling the Intricate Relationship
Alina-Teodora Nicu, Ileana Paula Ionel, Ileana Stoica, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1041-1041
Open Access | Times Cited: 2
Testicular cancer survivorship: Long-term toxicity and management
Noa Shani Shrem, Lori Wood, Robert J. Hamilton, et al.
Canadian Urological Association Journal (2022) Vol. 16, Iss. 8
Open Access | Times Cited: 12
DNA Methylation Biomarkers for Prediction of Response to Platinum-Based Chemotherapy: Where Do We Stand?
Nuno Tiago Tavares, Saulė Gumauskaitė, João Lobo, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2918-2918
Open Access | Times Cited: 9
Cisplatin causes erectile dysfunction by decreasing endothelial and smooth muscle content and inducing cavernosal nerve senescence in rats
Yinghao Yin, Yihong Zhou, Jun Zhou, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 5
H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets
Liliana Burlibașa, Alina-Teodora Nicu, Mariana Carmen Chifiriuc, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
An exploration of testicular cancer survivors’ experience of ejaculatory dysfunction following retroperitoneal lymph node dissection—a sub-study of the PREPARE clinical trial
Ciara Conduit, Amanda D. Hutchinson, Michael Leonard, et al.
Journal of Cancer Survivorship (2023)
Closed Access | Times Cited: 4
Primary Retroperitoneal Lymph Node Dissection for Clinical Stage II A/B Seminomas: A Systematic Review and Meta-Analysis
Bárbara Vieira Lima Aguiar Melão, Lucas Amorim, Murilo Ribeiro Sanches, et al.
International braz j urol (2024) Vol. 50, Iss. 4, pp. 415-432
Open Access | Times Cited: 1
Long Term Side Effects of Testicular Cancer and Treatment (Observational Study of Mortality and Morbidity in Testicular Cancer Survivors)
Manoranjan Khan, Patrice Kearney Sheehan, Ashley Bazin, et al.
(2024)
Open Access | Times Cited: 1
Association between low total serum testosterone and body mass index in Australian survivors of testicular cancer: a retrospective analysis
Grace Y. Kim, Ciara Conduit, Sophie O’Haire, et al.
Basic and Clinical Andrology (2024) Vol. 34, Iss. 1
Open Access | Times Cited: 1
Clinical stage II seminoma: management options
Muhannad Alsyouf, Siamak Daneshmand
World Journal of Urology (2021) Vol. 40, Iss. 2, pp. 343-348
Closed Access | Times Cited: 9
Associations of Body Fat Distribution and Cardiometabolic Risk of Testicular Cancer Survivors After Cisplatin-Based Chemotherapy
Andreas G. Wibmer, Paul C. Dinh, Lois B. Travis, et al.
JNCI Cancer Spectrum (2022) Vol. 6, Iss. 4
Open Access | Times Cited: 6
Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence
Ailsa J. Christiansen, João Lobo, Christian D. Fankhauser, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Cardiovascular Risks in Testicular Cancer: Assessment, Prevention, and Treatment
Suparna C. Clasen, Chunkit Fung, Howard D. Sesso, et al.
Current Oncology Reports (2023) Vol. 25, Iss. 5, pp. 445-454
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top